Professor, Surgery, Case Western Reserve University School of Medicine
General Surgery
Dr. Philip R. Schauer, MD
|
|
Give Review
Philip Schauer practices General Surgery. He went to Baylor College of Medicine. He has 4 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Whos Who in Medicine and Healthcare" and "Fellow (FACS)". Philip Schauer is a published doctor. He has 96 papers published. The most current publication "Factors associated with length of stay in intensive care after bariatric surgery." Philip R. Schauer accepts Medicare.
Publications
- Failure and Fatness: Could Surgical Management of Obesity Reduce Heart Failure Hospitalizations?
- Clinical and Echocardiographic Outcomes After Bariatric Surgery in Obese Patients With Left Ventricular Systolic Dysfunction.
- Reoperative Surgery for Management of Early Complications After Gastric Bypass.
- Comparison of Reinforcement Techniques Using Suture on Staple-Line in Sleeve Gastrectomy.
- Effect of Gastric Bypass vs Duodenal Switch on High-Density Lipoprotein Cholesterol Level.
- Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy.
- Revisional bariatric surgery can improve refractory metabolic Disease.
- Adults with long-duration type 2 diabetes have blunted glycemic and β-Cell function improvements after bariatric surgery.
- Primary silicone-banded laparoscopic sleeve gastrectomy: a pilot study.
- Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
- Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
- Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive m...
- How safe is metabolic/diabetes surgery?
- Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.
- Exploring the impact of bariatric surgery on high density lipoprotein.
- Bariatric Surgery, Kidney Function, Insulin Resistance, and Adipokines in Patients With Decreased GFR: A Cohort Study.
- Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
- Response to comments on Brethauer et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes care 2014;37:e51-e52.
- Safety and effectiveness of bariatric surgery in dialysis patients and kidney transplantation candidates.
- Pilot testing of a portion-controlled, commercially available diet on presurgical weight loss and metabolic outcomes in patients undergoing bariatric surgery.
- Outcomes of bariatric surgery in type 2 diabetic patients with diminished pancreatic secretory reserve.
- Assessment of the quality of internet information on sleeve gastrectomy.
- Bariatric surgery versus intensive medical therapy for diabetes.
- Outcomes of a third bariatric procedure for inadequate weight loss.
- Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience.
- Acute Pancreatitis in Patients After Bariatric Surgery: Incidence, Outcomes, and Risk Factors.
- Laparoscopic Bariatric Surgery Can Be Performed Through a Single Incision: A Comparative Study.
- The effect of bariatric surgery on gout: a comparative study.
- DiaRem score: external validation.
- Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass.
- Intellectual disability and bariatric surgery: a case study on optimization and outcome.
- Citation classics: Top 50 cited articles in bariatric and metabolic surgery.
- Banded Roux-en-Y gastric bypass for the treatment of morbid obesity.
- Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
- Revisional Bariatric Surgery for Unsuccessful Weight Loss and Complications.
- Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes.
- Surgical management of obesity and the relationship to cardiovascular Disease.
- The effect of selective gut stimulation on glucose metabolism after gastric bypass in the Zucker diabetic fatty rat model.
- Bariatric surgery and cardioVascular outcomes: a systematic review.
- Effects of Bariatric Surgery on Diabetic Nephropathy After 5 Years of Follow-Up.
- Bariatric surgery in patients with liver cirrhosis.
- Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2).
- Surgical management of early small bowel Obstruction after laparoscopic Roux-en-Y gastric bypass.
- Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial.
- Weighing the evidence for an association between obesity and suicide risk.
- Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles.
- Laparoscopic bariatric surgery for those with body mass index of 70-125 kg/m(2).
- Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients.
- Effect of Bariatric Surgery on CardioVascular Risk Profile.
- International Diabetes Federation position statement on bariatric surgery for type 2 diabetes: implications for patients, physicians, and surgeons.
- Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese.
- Reduced CardioVascular Risk Following Bariatric Surgeries is Related to a Partial Recovery from "Adiposopathy"
- Gastric Bypass Surgery Reduces Plasma Ceramide Subspecies and Improves Insulin Sensitivity in Severely Obese Patients.
- Erratum to: Early effects of gastric bypass on endothelial function, inflammation, and cardioVascular risk in obese patients.
- Early effects of gastric bypass on endothelial function, inflammation, and cardioVascular risk in obese patients.
- Laparoscopic gastric plication for treatment of severe obesity.
- Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients.
- Pancreatic islet isolation after gastric bypass in a rat model: technique and initial results for a promising research tool.
- Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients.
- Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery.
- Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis.
- Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action.
- Weight loss interventions in chronic kidney disease: a systematic review and meta-Analysis.
- Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver Disease in an obesity surgery cohort.
- Complications of gastric bypass: avoiding the Roux-en-O configuration.
- Systematic review of sleeve gastrectomy as staging and primary bariatric procedure.
- Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery.
- Selective nonoperative management of leaks after gastric bypass: lessons learned from 2675 consecutive patients.
- Inside the operating room--balancing the risks and benefits of new surgical procedures: a collection of perspectives and panel discussion.
- Death rates and causes of death after bariatric surgery for Pennsylvania residents, 1995 to 2004.
- Bariatric surgery training: getting your ticket punched.
- Risks and benefits of bariatric surgery: current evidence.
- Endoscopy and upper gastroIntestinal contrast studies are complementary in evaluation of weight regain after bariatric surgery.
- Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass.
- Laparoscopic repair of umbilical Hernias in conjunction with other laparoscopic procedures.
- Surgically-induced weight loss significantly improves nonalcoholic fatty liver Disease and the metabolic syndrome.
- Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass.
- Medicare and bariatric surgery.
- Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass.
- Jejunal gastroIntestinal stromal tumor: a cause of obscure gastroIntestinal bleeding.
- Medium-term follow-up confirms the safety and durability of laparoscopic ventral Hernia repair with PTFE.
- Outcomes of minimally invasive antireflux operations in the elderly: a comparative review.
- Minimally invasive esophagectomy: outcomes in 222 patients.
- Laparoscopic gastric bypass surgery: current technique.
- Open and laparoscopic surgical modalities for the management of obesity.
- Laparoscopic era of operations for morbid obesity.
- Nongynecologic advances in minimally invasive surgery.
- Results of laparoscopic repair of giant paraesophageal Hernias: 200 consecutive patients.
- Outcomes after minimally invasive reoperation for gastroesophageal reflux Disease.
- GastroIntestinal complications of laparoscopic Roux-en-Y gastric bypass surgery: clinical and imaging findings.
- Quality of life after antireflux surgery compared with nonoperative management for severe gastroesophageal reflux Disease.
- Malignant gastric carcinoid tumor and morbid obesity.
- Psoriasis improvement after bariatric surgery.
- Who Should Get Extended Thromboprophylaxis After Bariatric Surgery?: A Risk Assessment Tool to Guide Indications for Post-discharge Pharmacoprophylaxis.
- Factors associated with length of stay in intensive care after bariatric surgery.
Schools
Baylor College Of Medicine
Procedures Preformed
- Appendectomy, Laparoscopic
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Excision of Stomach Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Abdominal Pain
- Anal Fissure
- Atelectasis
- Biliary Atresia
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
- Fellow (FACS)
Education
-
University of Texas Health Science Center -
Baylor College of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1952494262 | |
| NPPES Provider LastName | SCHAUER | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | General Surgery | |
| Total Claim Count | 16.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952494262 |
| Last Name Of The Provider | SCHAUER |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
Dr. Craig M. Eyman, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger F. Classen, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel B. Anderson, MD |
|
|
Dr. Bijan Eghtesad, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Tracy L. Hull, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kresimira Milas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas P. Slawinski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clay C. Quint, MD |
|
|
Dr. Travis J. Mason, MD |